Skip to main content
Fig. 2 | BMC Research Notes

Fig. 2

From: Adherence to interferon β-1a therapy using an electronic self-injector in multiple sclerosis: a multicentre, single-arm, observational, phase IV study

Fig. 2

Proportion of participants with ≥80 % treatment adherence and compliance at week 12 and 24 (mITT population). Adherence calculated as 100 × the number of administered injections recorded in the electronic device log divided by the expected number of injections (e.g., 72 injections over 24 weeks). Compliance calculated as 100 times the number of injections recorded in the electronic device log divided by (the number of days on-study) × 3/7. mITT modified intent-to-treat

Back to article page

BMC Research Notes

ISSN: 1756-0500

Contact us